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Background: Conflicting results regarding the role of ARF6 in dendritic spine development have not been answered.
Results: ARF6-mediated Rac1 or RhoA activation via PLD pathway either positively or negatively regulates spine formation.
Conclusion: The key factor underlying conversion of the ARF6 effect during development is neuronal activity.
Significance:Activity dependence of ARF6-mediated spine formationmay play a role in structural plasticity ofmature neurons.
Recent studies have reported conflicting results regarding the
role of ARF6 in dendritic spine development, but no clear
answer for the controversy has been suggested. We found that
ADP-ribosylation factor 6 (ARF6) either positively or negatively
regulates dendritic spine formation depending on neuronal
maturation and activity. ARF6 activation increased the spine
formation in developing neurons, whereas it decreased spine
density in mature neurons. Genome-wide microarray analysis
revealed that ARF6 activation in each stage leads to opposite
patterns of expression of a subset of genes that are involved in
neuronal morphology. ARF6-mediated Rac1 activation via the
phospholipaseDpathway is the coincident factor in both stages,
but the antagonistic RhoA pathway becomes involved in the
mature stage. Furthermore, blocking neuronal activity in devel-
oping neurons using tetrodotoxin or enhancing the activity in
mature neurons using picrotoxin or chemical long term poten-
tiation reversed the effect of ARF6 on each stage. Thus, activity-
dependent dynamic changes inARF6-mediated spine structures
may play a role in structural plasticity of mature neurons.
Dendritic spines are actin-rich architectures that are impor-
tant for receiving presynaptic inputs in most excitatory syn-
apses in the central nervous system (1). These spines are flexible
structures, and their formation andmorphogenesis are dynam-
ically regulated through actin cytoskeletal reorganization (2).
The resulting changes are known to be cellular mechanisms
that modify brain activity such as the formation of long term
memory (3–5). Because of the presence of an extensive actin
cytoskeleton and the central role of actin in inducing morpho-
logical changes of spines in response to a variety of neural
events, proteins known to regulate actin cytoskeleton and the
associated signal pathways have been the primary targets of
studies focusing on spine formation and morphogenesis (6).
ADP-ribosylation factor 6 (ARF6)2 belongs to the ARF pro-
tein family, a Ras-related family of small GTPases that regulate
actin cytoskeleton and membrane trafficking (7, 8). ARF6 has
been known to play various roles in the regulation of cortical
actin dynamics and in membrane exchanges between the
plasma membrane and endocytic compartments (9). In the
nervous system, ARF6 has been shown to regulate neurotrans-
mitter release at the Xenopus neuromuscular junction via ARF
GEF msec7-1 and facilitate AP-2 and clathrin recruitments to
synaptic membranes (7). Furthermore, it was seen that ARF6
regulates early axonal and dendritic growth and branching (10,
11). Besides its involvement in early neuronal morphogenesis,
ARF6 is known to play a role in later stages of neuronal devel-
opment, and recent studies have reported that ARF6 affects
dendritic spine formation and causes morphological changes
(11–13). These studies, however, presented contradictory
results regarding the role of ARF6 in spine development.
Miyazaki et al. (12) found that a constitutively active mutant of
ARF6 (ARF6-Q67L) displayed a severe spine reduction in
mature hippocampal neurons (21 days in vitro (DIV 21)),
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whereas a dominant negative mutant of ARF6 (ARF6-T27N)
resulted in a substantial increase in spine density. Choi et al.
(13), however, showed that activation of ARF6 by overexpres-
sion of a fast cycling mutant of ARF6 (ARF6-T157A) increases
the spine density in developing neurons (DIV 11), whereas a
knockdown of ARF6 resulted in decreased spine formation.
Although several explanations regarding this controversy have
been suggested, it is still unclear whether ARF6 activation plays
a positive or negative role in spine development.
Here we showed that an activation of ARF6 differentially
regulates spine formation andmaintenance depending on neu-
ronal maturation and activity. In developing neurons, ARF6-
T157A, a fast cycling mutant of ARF6, increased the number of
dendritic spines via the ARF6/phospholipase D (PLD)/phos-
phatidic acid (PA) to PAK1-dependent (via guanine nucleotide
dissociation inhibitor for Rho proteins (RhoGDI)/Rac1) and/or
PAK1-independent pathway. Conversely, ARF6-T157A exhib-
ited a completely opposite effect in mature neurons, reducing
spine density by the balance between PLD-induced Rac1 and
RhoA activation and bypassing the PAK/RhoGDI pathway.
Consistent with these findings, genome-wide microarray anal-
ysis revealed that ARF6 activation in developing and mature
neurons leads to opposite patterns of expression of a subset of
genes that are involved in neuronal morphology. We further
demonstrated that the key factor underlying the conversion of
the ARF6 effect during development is neuronal activity
because blocking neuronal activity in developing neurons using
tetrodotoxin (TTX) or enhancing it in mature neurons using
picrotoxin (PTX) or chemically induced long term potentiation
(LTP) reversed the spine-promoting or spine-reducing effect of
ARF6-T157A, respectively.
EXPERIMENTAL PROCEDURES
Ethics Statement—Animal experimental procedures were
approved by the Institute of Animal Care and Use Committee
of Seoul National University, Korea (approval identification
number SNU-100930-5).
DNA Constructs and Reagents—Green fluorescent protein
(GFP)-5-phosphatase domain of synaptojanin-1 (5Ptase) and
GFP-RacDN (dominant negative mutant form; RacN17) were
kindly provided by Dr. Pietro De Camilli (Yale University, New
Haven, CT). GFP-PAK inhibitory domain (PID) was provided
by Dr. Dong-Eun Park (Seoul National University, Seoul, South
Korea), and GFP-RhoGDI1-S101A/S174A (mtRhoGDI) was
provided by Dr. Eung-Gook Kim (Chungbuk National Univer-
sity, Cheongju, South Korea). C-terminally HA-tagged wild-
typeARF6, ARF6-T27N (dominant negativemutant form), and
ARF6-T157A (fast cycling mutant form) were provided by Dr.
Eunjoon Kim (Korea Advanced Institute of Science and Tech-
nology, Daejeon, South Korea). ARF6-N48I and ARF6-T157A/
N48I were generated by site-directed point mutations using a
QuikChange site-directed mutagenesis kit (Stratagene, La
Jolla, CA). The fidelity of all constructs was verified by DNA
sequencing. All other reagents were from Sigma.
Hippocampal Neuron Culture and Transfection—Primary
rat hippocampal neurons were prepared as described (14).
Briefly, hippocampi were dissected from embryonic day 18
Sprague-Dawley fetal rats, dissociated with papain, and tritu-
rated with a polished half-bore Pasteur pipette. The cells (2.5
105) inminimumEagle’s medium supplemented with 0.6% glu-
cose, 1mMpyruvate, 2mM L-glutamine, 10% fetal bovine serum,
and antibiotics were plated on poly-D-lysine-coated glass cov-
erslips in a 60-mm Petri dish. Four hours after plating, the
medium was replaced with Neurobasal (Invitrogen) supple-
mented with 2% B-27 and 0.5 mM L-glutamine. 4 M 1--D-
cytosine arabinofuranoside was added as needed. Neurons
were transfected using the calcium phosphate method. Briefly,
empty vector (pcDNA3.0-HA), ARF6-T27N, ARF6-T157A,
ARF6-N48I, or ARF6-T157A/N48I with either GFP, GFP-
5Ptase, GFP-RhoGDI, or GFP-RacDN was either co-trans-
fected at DIV 11 and fixed at DIV 15 for developing stage or
co-transfected at DIV 16 and fixed at DIV 20 for mature stage.
Co-transfection was performed at a ratio of 1:3.
Pharmacological Treatments of Neurons at Either Developing
Stage or Mature Stage for Activity-dependent Spine Changes—
For global synaptic depression, 4 h after transfection at DIV 11
or 16, neurons were treated with 1MTTX for 4 days. Neurons
were fixed in 4%paraformaldehyde, 4% sucrose, PBS for 15min,
mounted, and stored at 4 °C for further imaging analysis. For
synaptic activity enhancement of mature neurons, 4 h after
transfection at DIV 11 or 16, neurons were treated with 50 M
PTX for 4 days. Neurons were fixed in 4% paraformaldehyde,
4% sucrose, PBS for 15 min, mounted, and stored at 4 °C for
further imaging analysis.
Chemical LTP Induction—Neuronswere co-transfectedwith
GFPwithHA or ARF6-T157A at DIV 11 or 16 using he calcium
phosphate method, and 9 h after transfection, these neurons
were subjected to chemically induced long term potentiation
(chem-LTP) as described (15). Briefly, transfected neurons
were placed inMg2-free extracellular solution (110 mMNaCl,
2 mM CaCl2, 5 mM KCl, 10 mM HEPES, 30 mM glucose, 0.5 M
TTX, 1 M strychnine, 20 M bicuculline methiodide, pH 7.4)
for 10 min at 37 °C in a CO2 incubator and then 200M glycine
was applied for 3 min at 37 °C in a CO2 incubator to induce
chem-LTP. After 20 min in extracellular solution, the neurons
were transferred to a dish containing the original medium. The
neurons were fixed at DIV 20, mounted, and stored at 4 °C for
further imaging analysis.
Microscopy and Image Analysis—Fluorescence images were
acquired on an Olympus IX-71 inverted microscope equipped
with a UPlanApo 40, 1.00 numerical aperture oil immersion
objective (Olympus, Tokyo, Japan), a GFP-optimized filter set
(Omega Optical, Brattleboro, VT), and an ORCA-R2 charge-
coupled device camera (Hamamatsu Photonics, Hamamatsu,
Japan) driven by MetaMorph Imaging software (Molecular
Devices, Sunnyvale, CA). Cells were excited with 480 nm light
(TouchBright X6, Live Cell Instrument, Seoul, South Korea).
MetaMorph Imaging software was used for analysis. For three-
dimensional structured illuminationmicroscopy (3D-SIM), we
used an N-SIMmicroscope system equipped with a Nikon CFI
Plan Apo IR 60, 1.27 numerical aperture water immersion
objective (Nikon, Tokyo, Japan) and an Andor DU-897 X-5834
EM charge-coupled device camera (Andor, Belfast, UK). The
channel was carefully aligned using an alignment parameter
from control measurements with 0.1-m-diameter fluorescent
beads. Image stacks of typically 1.0-m height with 33 images
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each and a z-distance of 0.03 m were acquired and computa-
tionally reconstructed. Reconstructed images were generated
in Blend Projection imageswith Imaris v7.5.2 (Bitplane, Zurich,
Switzerland) including volume rendering, rotations, and dis-
play adjustment to eliminate background noise and brighten
images. For analysis, well branched pyramidal or multipolar
neurons were randomly selected, and the experiments were
performed in a blinded manner. One to three secondary den-
drites in each neuronwere chosen. To determine the number of
dendritic spines and filopodia, spines were defined as dendritic
protrusions of 5 m in length with a head and filopodia as
dendritic protrusions of 10 m in length without apparent
heads. Spine head was defined as the tip structure that should
be at least 2 times thicker than the spine neck. Spines can be
morphologically classified into three types as follows: stubby,
thin, and mushroom-shaped (16). To distinguish spine types,
we defined spines as follows: the stubby type was defined as
spines devoid of an apparent neck, the thin type was defined as
spines having a thin neck and a small bulbous head, and the
mushroom type was defined as spines having a neck and a large
mushroom-shapedhead. The density and types of spines froma
single dendrite were grouped and averaged. Data are presented
as means S.E. Statistical analysis was carried out with PASW
Statistics 18 (formerly SPSS Statistics). Formultiple conditions,
we comparedmeans byANOVA followed by Tukey’s HSDpost
hoc test.
Generation of Recombinant Sindbis Viruses and Infection—
Sindbis viral constructs were kindly provided by Dr. Hyongkyu
Kim (Chungbuk National University). Generation of recombi-
nant Sindbis viruses expressing ARF6-T157A-His6 was per-
formed as described previously (17). For genome-wide
microarray analysis, rat hippocampal neuron cultures were
infected at DIV 10 for developing stage and DIV 17 for mature
stage and maintained for an additional 36 h. Infected neurons
were washed twice with PBS and stored at 70 °C for further
investigations. Samples were lysed, and RNA isolation was car-
ried out using the RNA-spin total RNA extraction kit (iNtRON
Biotechnology, Sungnam, Kyungki-Do, South Korea), and
genome-wide microarray analysis was performed.
Microarray Experiments—We prepared total RNA inde-
pendently from developing and mature neurons infected with
Sindbis virus-expressing ARF6-T157A and empty (CTL) vec-
tors using the RNeasymini kit (Qiagen, Valencia, CA).We ana-
lyzed a total of eight samples composed of duplicate samples in
the above four conditions. The RNA integrity of each sample
was assessed using Bioanalyzer 2100 (Agilent technologies,
Santa Clara, CA); the RNA integrity number was in the range
between 9.3 and 10 for all the four samples. RNA was reverse
transcribed, amplified, and then hybridized onto an Agilent
SurePrint G3 Rat GE Microarray 8 60,000 (including 62,976
probes corresponding to 19,958 annotated genes) according to
the Agilent standard protocols. The fluorescent signal on the
array was measured using an Agilent SureScan microarray
scanner. The probe intensities were converted to log2 intensi-
ties and then normalized using the quantile normalization
method (18). The normalized data were deposited in the Gene
Expression Omnibus (GEO) database under accession number
GSE40937.
Statistical Analysis of Gene Expression Data—Using the nor-
malized log2 intensities, the differentially expressed genes
(DEGs) between two conditions were identified as described
previously (19). Briefly, 1) Student’s t test and log2 median ratio
test were performed to compute T values and log2 median
ratios for all the genes. 2) Empirical distributions of the null
hypothesis were estimated by performing all possible combina-
tions of randompermutations of samples and then applying the
Gaussian kernel density estimationmethod toT values and log2
median ratios resulting from the random permutations (20). 3)
The adjusted p value of each gene for the individual tests was
computed by the two-tailed test using the empirical null distri-
bution. 4) The adjusted p values from the two tests were then
combined using Stouffer’s method (21). And finally, 5) the
DEGs were identified as the present genes with a combined p
value 0.1. To reduce false positives, we further selected only
DEGs whose absolute log2 -fold changes were larger than the
cutoff, the mean of 5th and 95th percentiles of the null distri-
bution of log2 -fold changes (0.372). Finally, gene ontology bio-
logical processes enriched by a list of genes were identified as
those with a p value0.05 using DAVID software (22).
RNA Interference—Small hairpin RNA (shRNA) for RNA
interference against rat PAK1 or rat ARF6 mRNA was
designed based on the rat PAK1 (GenBankTM accession
number NM_017198.1) or rat ARF6 (GenBank accession
number NM_024152) cDNA sequence, respectively. PAK1
was targeted to the region of nucleotides 1222–1240. Comple-
mentary oligonucleotides were synthesized separately with the
addition of a BamHI site at the 5-end and an EcoRI site at the
3-end. The forward targeting sequence of shRNA for PAK1
(shRNA-PAK1) was 5-GGATTCTGTGCACAGATAA-3.
ForARF6 targeting, the region of nucleotides 305–323was cho-
sen. Complementary oligonucleotides were synthesized sepa-
rately with the addition of a BamHI site at the 5-end and an
EcoRI site at the 3-end. The forward targeting sequence of
shRNA for ARF6 (shRNA-ARF6) was 5-AGCTGCACCGCA-
TTATCAA-3. The annealed cDNA fragments were cloned
into the BamHI-EcoRI sites of the vector pSIREN-DNR-
DsRed-Express (BD Biosciences). The efficiency of shRNAs
was tested on protein levels of HA-tagged rat PAK1 or rat ARF6
in HEK293T cells (data not shown). Both PAK1 and ARF6 tar-
geting sequences have been already reported (13, 23). The fidel-
ity of all constructs was verified by sequencing.
RESULTS ANDDISCUSSION
The Number of Spines Increases Exponentially during DIV
11–15—To evaluate dendritic spine formation during neuronal
development, neurons were transfected withGFP at DIV 7, and
spine numbers were counted during neuronal development.
We defined dendritic spines as protrusions of 0.5–5 m in
length with a head. The number of spines increased duringDIV
11–15 and reached a plateau at later stages (Fig. 1 A). We
defined the developing stage of a neuron as when spine devel-
opment shows exponential growth (DIV 11–15), whereas the
mature stage was when it reaches a plateau (DIV 17–20). The
ratio of spines versus filopodia also increased as neurons
matured (Fig. 1B).
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Spines can be morphologically divided into three types as
follows: thin, stubby, andmushroom-shaped. The thin typewas
defined as spines having a long thin neck and a small bulbous
head, the stubby type was defined as those devoid of a neck, and
the mushroom-shaped type was defined as those having a neck
and a large head. The portion of different morphological types
of spines changed with an increase in the proportion of mush-
room-shaped spines and a concomitant reduction in the pro-
portion of thin and stubby spines (Fig. 1C).
ARF6 Distinctly Modulates Dendritic Spine Formation at
Each Stage—To determine the role of ARF6 in spine formation
at the developing stage, we co-transfected neurons at DIV 11
with a fast cycling mutant of ARF6 (ARF6-T157A), a dominant
negative mutant of ARF6 (ARF6-T27N), or an empty vector
(HA) with GFP and fixed cells at DIV 15. Overexpression of
ARF6-T157A significantly increased the number of spines,
whereas overexpression ofARF6-T27N showed no change (Fig.
2, A and B, and Tables 1 and 2). These results are consistent
with a previous report (13), confirming that ARF6 activation
positively regulates spine formation in developing neurons.
Next, we investigated the roles of active ARF6 at the mature
stage of neurons. We co-transfected neurons with ARF6-
T157A, ARF6-T27N, or HA with GFP at DIV 16, and the cells
were fixed at DIV 20. In contrast to the results of developing
neurons, ARF6-T157A significantly decreased the number of
spines, whereas ARF6-T27N promoted spine formation (Fig. 2,
C and D), which is consistent with a previous report (12), con-
firming that ARF6 activation negatively regulates spine forma-
tion in mature neurons.
Active ARF6 Promotes Dendritic Spine Formation in Devel-
opingNeurons—ARF6 is known to activate various downstream
pathways including PLD, phosphatidylinositol 4-phosphate
5-kinases, and Rac1 (7). To test which pathway(s) is involved in
the spine-promoting effect of ARF6 at the developing stage, we
first co-transfected neurons with GFP and ARF6-N48I, which
prevents activation of PLD, or ARF6-T157A/N48I at DIV 11,
and the cellswere fixed atDIV15.We found thatARF6-T157A/
N48I completely abrogated the spine-promoting effect of
ARF6-T157A,whereasARF6-N48I alone had no effect on spine
formation (Fig. 3A). These results suggest that the spine-pro-
moting effect of ARF6-T157A in developing neurons is mainly
mediated through the PLD pathway.
The prominent downstream candidate for PLD/PA-medi-
ated spine development is PAK1, a serine/threonine kinase that
regulates the actin cytoskeleton (24). The role of PAK1 in spine
regulation has been firmly established by a number of previous
studies (25, 26). To test whether PAK1 is involved in ARF6/
PLD-mediated spine regulation in developing neurons, we co-
transfected neurons with ARF6-T157A and PID, an autoinhibi-
tory domain of PAK1. PID alone reduced spine density,
FIGURE1.Developmental changesofdendritic spine formation in ratprimary culturedhippocampalneurons.A, culturedneuronswere transfectedwith
GFPatDIV 7 and then fixed at the indicatedDIV. Spinedensity rises duringDIV11–15, and then the levels persist. Datawere collected from three coverslipswith
each having two dendrites from three neurons at the indicated DIV. B, representative images for spines at the indicated DIV and a ratio graph of spines versus
filopodia are depicted.C, pie graphs illustrating the changes in theportionof differentmorphological types of spineprotrusions in theneurons expressingGFP
depending on developmental stages.
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suggesting that in the resting state spine formation is regulated
endogenously by PAK1 via an ARF6-independent pathway(s)
(Fig. 3B). Co-expression of PID completely eliminated the
effect of ARF6-T157A, indicating the involvement of theARF6/
PLD/PA/PAK1 pathway. The difference between PID alone
and PID with ARF6-T157A also suggests that an ARF6-depen-
dent but PAK1-independent pathway could be involved in
ARF6-T157A-mediated spine formation (Fig. 3B; see also
Fig. 7).
RhoGDI is known to be a downstream effector of PAK1 (27).
RhoGDI phosphorylation by PAK1 dissociates Rac1 from
RhoGDI, allowing subsequent Rac1 activation by Rac guanine
nucleotide exchange factors (27). Because previous studies
showed that the spine-promoting effect of ARF6 is partially
blocked by a dominant negative Rac1 (13), we tested the
involvement of the PAK1/RhoGDI pathway using ARF6-
T157A. We co-transfected neurons with ARF6-T157A or HA
andmtRhoGDI, which cannot be phosphorylated by PAK1.We
found that mtRhoGDI completely abrogated the effect of
ARF6-T157A (Fig. 3C). Consistently, we also found that RacDN
largely blocked ARF6-T157A-induced spine formation (Fig.
3D).
PA can also activate phosphatidylinositol 4-phosphate 5-ki-
nases, leading to an increase in the production of phosphatidy-
linositol 4,5-bisphosphate (PIP2) (28). We found that co-trans-
fection of ARF6-T157A or HA and GFP-tagged 5Ptase, which
reduces cellular PIP2 levels, reversed the effect of ARF6-T157A.
In addition, 5Ptase alone reduced spine density (Fig. 3E).
FIGURE 2.ARF6 differentially regulates dendritic spine formation in developing andmature neurons. A, representative images for developing neurons.
Cultured hippocampal neurons were co-transfected at DIV 11 with T157A-ARF6-HA, T27N-ARF6-HA, or pcDNA3.0-HA (HA), and pEGFP-c1 and fixed at DIV 15.
Inset imageswere acquired by three-dimensional structured illuminationmicroscopy andwere reconstructed by surface area rendering using Imaris software.
Scale bars, 10m.B, quantificationof the effect of ARF6mutants ondendritic spine formation. The values in the spinenumber graphwere recalculated to show
percent differences between each group and HA. Detailed data are shown in Table 1. Data were collected for each group in three independent experiments.
The values aremeans S.E.Daggers (†) indicate the significance between HA and each group, and asterisks (*) indicate the significance between each group.
††† and ***, p  0.001 (ANOVA and Tukey’s HSD post hoc test). C, representative images for mature neurons. Cultured hippocampal neurons were co-
transfected atDIV 16with T157A-ARF6-HA, T27N-ARF6-HA, or HA andGFP and fixed atDIV 20. Scale bars, 10m.D, quantification of the effect of ARF6mutants
on dendritic spine formation. The values in the spine number graphwere recalculated to show the differences between each group and HA. Detailed data are
shown in Table 2. Data were collected for each group in three independent experiments. The values are means  S.E. ††† and ***, p  0.001 (ANOVA and
Tukey’s HSD post hoc test). Error bars represent S.E.
TABLE 1
Data for ARF6-T157A sets of developing neurons
Sample name










GFP HA 4.49 0.08 0 1.68 11 25 50
GFP T157A-HA 5.69 0.07 26.77 1.59 13 28 56
GFP T27N-HA 4.32 0.10 3.81 2.33 12 26 52
GFP N48I-HA 4.39 0.08 2.13 1.86 5 14 28
GFP T157A/N48I-HA 4.68 0.04 4.20 0.88 5 14 26
GFP-PID HA 3.29 0.10 26.62 2.12 6 16 32
GFP-PID T157A-HA 4.54 0.11 1.04 2.40 5 14 28
GFP-mtRhoGDI HA 1.91 0.05 57.42 1.06 6 15 30
GFP-mtRhoGDI T157A-HA 2.72 0.06 39.44 1.36 7 16 32
GFP-RacDN HA 2.08 0.21 53.56 4.61 6 15 30
GFP-RacDN T157A-HA 2.72 0.15 39.32 3.24 8 16 32
GFP-5Ptase HA 3.58 0.08 20.21 1.85 4 14 28
GFP-5Ptase T157A-HA 4.48 0.11 0.21 2.48 4 14 28
TTX GFP HA 5.16 0.19 14.84 4.31 10 18 36
TTX GFP T157A-HA 2.92 0.10 34.86 2.17 9 20 40
PTX GFP HA 5.22 0.08 15.25 2.77 5 15 30
PTX GFP T157A-HA 5.87 0.18 28.05 4.23 4 12 24
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Data for ARF6-T157A sets of mature neurons
cLTP, chemically induced LTP.
Sample name










GFP HA 4.75 0.06 0 1.34 19 38 62
GFP T157A-HA 3.44 0.06 27.70 1.33 16 32 64
GFP T27N-HA 5.90 0.25 24.01 5.28 7 17 33
GFP N48I-HA 4.65 0.11 2.24 2.25 5 14 26
GFP T157A/N48I-HA 4.46 0.19 6.12 3.89 4 13 26
GFP-PID HA 2.95 0.11 38.02 2.31 5 13 26
GFP-PID T157A-HA 2.99 0.09 37.10 1.85 6 15 30
GFP-mtRhoGDI HA 3.33 0.06 29.91 1.17 5 15 30
GFP-mtRhoGDI T157A-HA 2.87 0.05 39.65 1.12 5 14 28
GFP-RacDN HA 3.96 0.11 16.61 2.28 5 12 24
GFP-RacDN T157A-HA 4.75 0.15 0.08 3.05 4 11 22
GFP-5Ptase HA 3.42 0.21 28.14 4.34 6 13 26
GFP-5Ptase T157A-HA 3.10 0.31 34.85 6.43 5 12 24
TTX GFP HA 4.15 0.11 12.66 2.41 5 13 26
TTX GFP T157A-HA 3.34 0.06 29.70 1.33 5 13 26
PTX GFP HA 5.08 0.06 6.84 1.21 5 14 28
PTX GFP T157A-HA 4.90 0.13 2.97 2.65 4 13 26
cLTP GFP HA 5.58 0.17 17.44 3.55 4 13 26
cLTP GFP T157A-HA 4.75 0.09 0.04 1.86 5 15 30
FIGURE3.TheeffectsofARF6-T157AorARF6knockdownondendritic spine formation indevelopingneurons.A–E, culturedhippocampal neuronswere
co-transfected at DIV 11 with T157A-ARF6-HA, T157A/N48I-ARF6-HA, N48I-ARF6-HA, or HA and GFP (A), T157A-ARF6-HA or HA and GFP or GFP-PID (B),
T157A-ARF6-HAorHAandGFPorGFP-mtRhoGDI (C), T157A-ARF6-HAorHAandGFPorGFP-RacDN (D), or T157A-ARF6-HAorHAandGFPorGFP-5Ptase (E) and
fixed at DIV 15. The effects of ARF6mutants on dendritic spine formation were quantified to investigate the PLD/PA pathway. The values in the spine number
graph were recalculated to show percent differences between each group and HA. Detailed data are shown in Table 1. Data were collected for each group in
three independent experiments. ††† and ***, p  0.001; **, p  0.01; NS, not significant (ANOVA and Tukey’s HSD post hoc test). F, cultured hippocampal
neurons were co-transfected at DIV 11 with T157A-ARF6-HA or HA and pSIREN-empty (control (Ctrl) vector), shRNA-PAK1, or shRNA-ARF6 and fixed at DIV 15.
The effect of ARF6-T157A with PAK1 depletion or ARF6 depletion on dendritic spine formation was quantified in developing neurons. The values in the spine
number graphwere recalculated to show the differences between each group andHA. Detailed data are shown in Table 3. Datawere collected for each group
in three independent experiments. The values are means S.E. ††† and ***, p 0.001 (ANOVA and Tukey’s HSD post hoc test). Error bars represent S.E.
Differential Role of ARF6 in Dendritic Spine Formation
7328 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 290•NUMBER 12•MARCH 20, 2015
 at PO
STECH









Because it is already known that PIP2 at the plasma membrane
is required for proper GDP/GTP exchange on Rac1 where Rac1
regulates actin cytoskeleton (29), we hypothesized that the
negating effect of 5Ptase onARF6-T157Amight bemediated by
hampering Rac1 recruitment and activation at the plasma
membrane.
These results suggest that the ARF6/PLD/PA to PAK1-de-
pendent (via RhoGDI/Rac1) and/or PAK1-independent path-
way is significant in the spine-promoting effect of ARF6 in
developing neurons (see also Fig. 7). The above results were
further corroborated by the results from knockdown of endog-
enous PAK1 (Fig. 3F andTable 3). Suppression of PAK1 expres-
sion by shRNA-PAK1 alone reduced spine density, and co-ex-
pression of shRNA-PAK1 and ARF6-T157A completely
eliminated the effect of ARF6-T157A. Again, the difference
between shRNA-PAK1 alone and shRNA-PAK1 with ARF6-
T157A also suggests that an ARF6-dependent but PAK1-inde-
pendent pathway could be involved in ARF6-T157A-mediated
spine formation (Fig. 3F). The knockdownof endogenousARF6
alone reduced spine density (Fig. 3F), whichmight be from side
effects of knockdown considering the involvement of ARF6 in a
wide variety of cellular processes.
Active ARF6 Inhibits Dendritic Spine Formation in Mature
Neurons—In mature neurons, the PLD pathway is also the
major pathway for the spine-reducing effect of ARF6-T157A
because ARF6-T157A/N48I largely abrogated the effect of
ARF6-T157A,whereasARF6-N48I alone had no effect on spine
formation (Fig. 4 A). However, co-expression of PID did not
eliminate the spine-reducing effect of ARF6-T157A (Fig. 4B).
Also, introducing mtRhoGDI did not abolish the effect of
ARF6-T157A. Interestingly, PID or mtRhoGDI itself reduced
the spine density, which is consistent with the result from
developing neurons (Figs. 3, B and C, and 4, B and C). These
results suggest that in the resting state the ARF-independent
PAK/RhoGDI pathway is important for spine maintenance in
both developing neurons and mature neurons.
For mature neurons, we introduced another PLD down-
stream pathway, the RhoA pathway, in addition to the Rac1
pathway. Previously, we showed that unlike Rac1, which is
expressed at high levels from the early stage and persists
throughout development, RhoA expression levels are low at the
early developmental stage but gradually increase, and after DIV
20, its expression levels are comparable with those of Rac1 (30).
Besides, it is well known that RhoA and Rac1 exert antagonistic
effects in spine development: RhoA plays a negative role,
whereas Rac1 plays a positive role (31). Because the previous
studies showed that PLD or PA is directly recruited to the
plasma membrane and activates Rac1 or RhoA (32–34), we
hypothesized that the balance between ARF6-T157A-induced
Rac1 and RhoA activation via the PLD pathway, bypassing the
PAK/RhoGDI pathway, plays a key role in the spine-reducing
effect of ARF6-T157A in mature neurons (see also Fig. 7).
Accordingly, RacDN alone reduced spine density and almost
completely reversed the effect of ARF6-T157A in mature neu-
rons (Fig. 4D). The phosphatidylinositol 4-phosphate 5-kinase/
PIP2 pathway is not involved in the effect of ARF6 because
co-transfection of ARF6-T157A with 5Ptase failed to recover
spine density but rather induced a further decrease (Fig. 4E).
Suppression of PAK1 expression by shRNA-PAK1 alone
reduced spine density, and co-expression of shRNA-PAK1 and
ARF6-T157A did not abolish the effect of ARF6-T157A (Fig.
4F), which is consistent with the results from examination of
the PID effect (Fig. 4B). The knockdown of endogenous ARF6
alone also reduced spine density in mature neurons (Fig. 4F).
Overexpression of Active ARF6 Alters Gene Transcription
Profiles Differentially at Developing and Mature Stages—How
does the same ARF activation mediate completely opposite
effects on spine regulation depending on the level of neuronal
maturation? To answer this question, we performed genome-
wide gene expression profiling of developing (DIV 12) and
mature neurons (DIV 19) infectedwith Sindbis virus expressing
ARF6-T157A and CTL vectors to determine the downstream
target genes affected byARF6 in the two types of neurons. First,
we generated Sindbis viruses and checked the expressions of
ARF6 mRNA and protein levels. Neurons infected by Sindbis
virus expressing ARF6-T157A exhibited strong expressions of
both ARF6 mRNA and protein levels (Fig. 5, A and B), and the
infection efficiency and cell viability of cells we had used were
confirmed by immunostaining and the pyknotic viability test
during a 36-h infection with Sindbis virus expressing ARF6-
T157A-His6 (Fig. 5C and data not shown). We identified 1,690
and 1,426 DEGs from the following two comparisons (total of
2,872 DEGs): 1) ARF6-T157A versus CTL in developing neu-
rons and 2) ARF6-T157A versus CTL in mature neurons (Fig.
5D). To systematically explore the association of the two sets of
DEGs with the differential roles of ARF6 in spine formation, we
categorized the 2,872 DEGs into eight possible clusters (C1–
C8) based onup- anddown-regulation patterns in the two com-
parisons. Among the eight clusters, we focused on four major
clusters (C1–C4; Fig. 5E) containing greater than 100 genes. To
TABLE 3
Data for sets of shRNA-PAK1 and shRNA-ARF6 in both stages of neurons
Ctrl, control.
Stage Sample name










Developing Ctrl vectorHA 4.43 0.10 0 2.33 8 20 40
Ctrl vector T157A-HA 5.67 0.13 27.91 2.88 6 16 32
shRNA-PAK1HA 3.55 0.11 28.68 9.17 8 20 40
shRNA-PAK1 T157A-HA 4.47 0.12 1.00 2.63 7 18 36
shRNA-ARF6HA 3.25 0.08 26.51 1.74 5 14 28
Mature Ctrl vectorHA 4.80 0.13 0 2.69 9 24 48
Ctrl vector T157A-HA 3.36 0.11 29.95 2.19 7 18 36
shRNA-PAK1HA 4.24 0.11 11.61 2.19 5 14 28
shRNA-PAK1 T157A-HA 4.00 0.14 16.67 2.81 6 16 32
shRNA-ARF6HA 3.75 0.11 21.77 2.26 8 20 40
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understand cellular processes represented by the genes in these
individual clusters, we performed enrichment analysis of gene
ontology biological processes for the genes in each cluster (Fig.
5F). The results showed that DEGs are mainly involved in neu-
ronal activity-related processes (synaptic transmission, learn-
ing or memory, and calcium ion homeostasis) and neuronal
development and morphogenesis (neuron differentiation, reg-
ulation of nervous system development, axonogenesis, and cell
motility). Intriguingly, neuronal morphology-related processes
such as axonogenesis and cell motility involving actin cytoskel-
eton reorganization are regulated predominantly by the genes
in C2, which are up-regulated by ARF6 in developing neurons
but not in mature neurons. Conversely, the neuronal activity-
related processes such as synaptic transmission and learning or
memory are regulated predominantly by the genes in C3, which
are down-regulated by ARF6 in developing neurons but not in
mature neurons. These data indicate that ARF6 activation in
developing and mature neurons leads to different expression
patterns between developing andmature neurons for the afore-
mentioned genes (C1 and C3) associated with actin cytoskele-
ton reorganization and neuronal activity-related processes.
ARF6-mediated Spine Formation Is Regulated by Neuronal
Activity—During the developing stage between DIV 11 and 15,
neurons undergo drastic activity-dependent structural and
functional rearrangements, which are later stabilized at the
mature stage (35, 36). We reasoned that such neuronal activity
could be the key factor for the conversion of the effect of ARF6
on spine development. We first tested this possibility in devel-
oping neurons. When we treated developing neurons with
TTX, which blocks action potential generation in neurons and
causes a global inhibition of neuronal activity (37), neurons
having longer thin spinelike protrusions became amajority.We
found that TTX treatment completely blocked the spine-pro-
moting effect of ARF6-T157A, inducing longer thin spinelike
protrusions (Fig. 6 A). To verify whether the effect of ARF6 on
spine formation in mature neurons is dependent on neuronal
activity, we treated mature neurons with PTX, a noncompeti-
tive antagonist for the GABAA receptor, thus increasing neuro-
FIGURE 4. The effects of ARF6-T157A or ARF6 knockdown on dendritic spine formation in mature neurons. A–D, Cultured hippocampal neurons were co-
transfected at DIV 16with T157A-ARF6-HA, T157A/N48I-ARF6-HA, N48I-ARF6-HA, or HA andGFP (A), T157A-ARF6-HA or HA andGFP or GFP-PID (B), T157A-ARF6-HA
or HA andGFP or GFP-mtRhoGDI (C), T157A-ARF6-HA or HA andGFP or GFP-RacDN (D), or T157A-ARF6-HA or HA andGFP or GFP-5Ptase (E) and fixed at DIV 20. The
effect of ARF6mutants on dendritic spine formationwas quantified to investigate the PLD/PA pathway. The values in the spine number graphwere recalculated to
showpercentdifferencesbetweeneachgroupandHA.DetaileddataareshowninTable2.Datawerecollected foreachgroup in three independentexperiments. The
values aremeansS.E.Daggers (†) indicate the significancebetweenHAandeachgroup, andasterisks (*) indicate the significancebetweeneachgroup. †††and ***,
p 0.001; **, p 0.01; *, p 0.05;NS, not significant (ANOVA and Tukey’s HSD post hoc test). F, cultured hippocampal neurons were co-transfected at DIV 16 with
T157A-ARF6-HA or HA and pSIREN-empty (control (Ctrl) vector), shRNA-PAK1, or shRNA-ARF6 and fixed at DIV 20. The effect of ARF6-T157Awith PAK1 depletion or
ARF6depletionondendritic spine formationwasquantified inmatureneurons. Thevalues in the spinenumbergraphwere recalculated to showpercentdifferences
between each group andHA. Detailed data are shown in Table 3. Datawere collected for each group in three independent experiments. †††, p 0.001; † and *, p
0.05;NS, not significant (ANOVA and Tukey’s HSDpost hoc test). Error bars represent S.E.
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nal activity (38).We discovered that PTX treatment completely
blocked the spine-reducing effect of ARF6-T157A in mature
neurons (Fig. 6D).
When we treated mature neurons with TTX or developing
neurons with PTX, neither treatment affected the ARF6-
T157A effect (Fig. 6,B andC). In addition, we used the protocol
FIGURE 5.Differential gene expression patterns between developing andmature neurons. A, cultured hippocampal neurons were infected at DIV 10 or
17with Sindbis empty virus (Ctrl) or T157A-ARF6-His6 virus (T157A). Thirty-six hours after infection, the cells were lysed and immunoblotted with anti-ARF6
antibody or anti--tubulin (Tub) antibody. WB, Western blot. B, the neuronal mRNAs were extracted from sister cultures, and the mRNA level of ARF6
expression was quantified. The values on top of bars indicate the mean of ARF6 mRNA level in each group. C, representative images of ARF6 expression
after T157A infection. The efficiency of T157A infection in cultured hippocampal neurons wasmeasured by counting neurons co-stained with anti-ARF6
antibody and DAPI or singly stained with DAPI. D, a Venn diagram showing relationships between DEGs from the following two comparisons: 1)
ARF6-T157A versus CTL in developing neurons (ARF6 d12 vs CTL d12) and 2) ARF6-T157A versus CTL inmature neurons (ARF6 d19 vs CTL d19). E, a heatmap
showing up- and down-regulation of the genes in the four major clusters (C1–C4). Numbers in parentheses, numbers of the genes in the clusters. Red and
green, up- and down-regulation of the genes, respectively. Color bar, gradient of log2 -fold changes. F, a heatmap representing the degree of enrichment
of the genes involved in each gene ontology biological process in the four major clusters. Color bar, gradient of proportion of the genes involved in each
gene ontology biological process in a cluster. Error bars represent S.E. TGFBR, TGF- receptor.
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for chem-LTP, which has been shown previously to increase
global neuronal activity in cultured neurons (39). After trans-
fecting neurons with ARF6-T157A at DIV 16, chem-LTP was
induced, andneuronswere fixed and analyzed atDIV20. Fig. 6E
shows that chem-LTP successfully blocked the spine-reducing
effect of ARF6-T157A in mature neurons.
ARF6 is the only member of the ARF family that can simul-
taneously regulate actin cytoskeleton changes and membrane
exchange between the plasma membrane and endocytic com-
partments. ARF6 is present in the developing neurites and later
on in dendrites, possibly suggesting a role for ARF6 in the pro-
cesses of dendritic initiation, elongation, and branching (40,
41). Hernández-Deviez et al. (11) showed that overexpression
of ARF6-T27N in young hippocampal neurons leads to a dra-
matic increase in the total number of dendrites, whereas ARF6-
Q67L results in a reduction of dendritic tree complexity.
Miyazaki et al. (12) reported that overexpression ofwild-type or
constitutively active Q67L mutant of ARF6 significantly
decreases the number of spines in mature neurons, whereas
overexpression of ARF6-T27Nmarkedly increases the number
of spines. In contrast, Choi et al. (13) showed that ARF6 activa-
tion promotes the conversion of dendritic filopodia to spines
and increases spine density at an early stage, whereas depletion
of endogenousARF6 leads to a decrease in the number of spines
and an increase in the number of filopodia. Raemaekers et al.
(43) also confirmed the increase in spine number in hippocam-
pal neurons overexpressing ARF6-T157Amutant. Various fac-
tors such as types of mutants, the spatiotemporal activation of
GEFs or GTPase-activating proteins, and overexpression-in-
duced artifacts may explain the conflicting results, but no clear
FIGURE 6.ARF6-T157A regulates dendritic spine formationdependingonneuronal activity.A, culturedhippocampal neuronswere co-transfected atDIV
11 with T157A-ARF6-HA or HA and GFP, subsequently treated with or without 1M TTX, and then fixed at DIV 15. The effect of ARF6-T157A on dendritic spine
formationwith orwithout TTX treatmentwas quantified. B, cultured hippocampal neuronswere co-transfected at DIV 11with T157A-ARF6-HA or HA andGFP,
subsequently treatedwithorwithout 50MPTX, and then fixedatDIV15. Theeffect ofARF6-T157Aondendritic spine formationwithorwithoutPTX treatment
was quantified. The values in the spine number graphwere recalculated to showpercent differences between each group andHA. Detailed data are shown in
Table 1. Data were collected for each group in three independent experiments. The values are means S.E. ††† and ***, p 0.001; †† and **, p 0.01; *, p
0.05; NS, not significant (ANOVA and Tukey’s HSD post hoc test). C, cultured hippocampal neurons were co-transfected at DIV 16 with T157A-ARF6-HA or HA
and GFP, subsequently treated with or without 1M TTX, and then fixed at DIV 20. The effect of ARF6-T157A on dendritic spine formation with or without TTX
treatment was quantified.D, cultured hippocampal neurons were co-transfected at DIV 16 with T157A-ARF6-HA or HA and GFP, subsequently treated with or
without 50M PTX, and then fixed at DIV 20. The effect of ARF6-T157A on dendritic spine formationwith or without PTX treatment was quantified. E, cultured
hippocampal neuronswere co-transfected atDIV 16with T157A-ARF6-HAorHA andGFP. Nine hours after transfection, transfected neuronswere subjected to
chem-LTP (cLTP) induction and fixed and analyzed at DIV 20. The effect of ARF6-T157A on dendritic spine formation in neurons with or without chem-LTP
inductionwas quantified. The values in the spine number graphwere recalculated to showpercent differences between each group andHA. Detailed data are
shown in Table 2. Datawere collected for each group in three independent experiments. The values aremeans S.E. ††† and ***, p 0.001;NS, not significant
(ANOVA and Tukey’s HSD post hoc test). Error bars represent S.E.
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answer has been suggested. We found that activation of ARF6
could either positively or negatively regulate dendritic spine
formation depending on neuronalmaturation and activity, thus
providing a reconciling answer for the controversy on the role
of ARF6.
We found that Rac1 activation via PLD is the coincident fac-
tor in developing or mature neurons, but in mature neurons,
RhoA activation antagonizes the spine-promoting effect of
Rac1. Levels of Rac1 in the mouse CNS are initially high in the
embryo and decrease steadily after birth, suggesting that Rac1
activity in the CNS is required for spine formation andmatura-
tion in developing neurons (44). Previous studies also found
that Rac1 appears to be important in two successive steps of
spine morphogenesis: the conversion between longer filopodi-
um-like protrusions and short, thin spines in developing stages
and then later in spine head growth in mature stages either by
inducing these processes or by inhibiting their reverse pro-
cesses (45). On the contrary, the developmental expression pat-
tern of RhoA appears to be the opposite in that its levels were
low in the early stage of development and increase gradually
during development (30). Because it is well known that RhoA
andRac1have an antagonistic effect to each other (46), together
with our current results, Rac1 activity seems to be a key deter-
minant for spine formation and maturation in developing neu-
rons, whereas in mature neurons, RhoA takes over the control,
and the balance between RhoA and Rac1 activity regulates the
formation and maintenance of mature spine structures.
In addition toRac1, PIP2 is also involved in actin cytoskeleton
rearrangement as well as membrane trafficking (47). PIP2 has
been found in various intracellular compartments including the
cytosolic face of the plasma membrane and is able to activate
and/or recruit actin regulatory proteins such as myristoylated
alanine-richCkinase substrate and cofilin, suggesting thatmul-
tiple functional roles of PIP2 could co-exist (48, 49). ARF6 can
induce PIP2 production by modulating PLD/PA-dependent or
-independent phosphatidylinositol 4-phosphate 5-kinase acti-
vation, leading to regulation of exo/endocytosis and changes in
the actin cytoskeleton (7). Although we found that reducing
PIP2 levels using 5Ptase reversed the effect of ARF6-T157A in
developing neurons but failed to reverse the ARF6-T157A
effect in mature neurons because 5Ptase alone mostly reduced
spine density in both developing neurons and mature neurons,
we assume that the effect of 5Ptase might not be related to
ARF6, although we cannot rule out the possibility that ARF6
activation may exert effects on spine via PIP2.
Based on current and previously published results, here we
propose signaling pathways mediated by ARF6 activation to
regulate spine formation in developing and mature neurons
(Fig. 7). In developing neurons, three routes are in operation,
and all converge on Rac1 to promote spine formation: Route 1,
ARF6-dependent but PAK1-independent pathway; Route 2,
ARF6-independent but PAK1-dependent pathway; and Route
3, ARF6- and PAK1-dependent pathway. In mature neurons,
another route is in operation: Route 4 inwhich anARF6-depen-
dent and Rho-dependent pathway provides a strong negative
impact on spine formation. Using these routes, we are able to
explain reasonably well the experimental data we obtained in
Figs. 3 and 4. However, it is surely a too simplified abstraction
considering the involvement of ARF6 in various other cellular
signaling pathways and current microarray data in which thou-
sands of genes were affected by ARF6 activation. A more
detailed analysis of the levels of the signaling network is
required in future work.
Neuronal activity such as LTP and long term depression
induces changes in both motility and shape that are morpho-
logical correlates of synaptic plasticity (6). Here we demon-
strate that TTX treatment of developing neurons or PTX treat-
ment of mature neurons expressing ARF6-T157A completely
abrogated the effect of ARF6-T157A on spine formation (Fig. 6,
A andD). Therefore, our results suggest that neuronal activity is
the key regulator for bidirectional regulation ofARF6-T157A in
spine formation. Our results also suggest that Rac1 activity and
neuronal activity are highly correlated in inducing spine forma-
tion and maintenance.
Growing evidence suggests that ARF6 activation is precisely
regulated byARF6GEFs in a spatiotemporalmanner, leading to
neuronal development and synapse formation (7, 50). Cytohe-
sin1 and -2, EFA6A–D, and brefeldin A-resistant ARF-GEF1-3
are well known positive regulators for ARF6 activation (51).
Cytohesin2 (also called ARF nucleotide-binding site opener)
inactivation causes an increase in dendritic branching, and
EFA6A depletion decreases dendritic spine density in hip-
pocampal neurons (11, 13). The brefeldin A-resistant ARF-
FIGURE 7. Hypothetical models of ARF6 signaling pathways for regulat-
ing spine formation. In developing neurons, three routes are in operation,
and all converge on Rac1 to promote spine formation. A, Route 1: ARF6-de-
pendent but PAK1-independent pathway (ARF6/PLD/PA/Rac) that explains
the difference between PID alone and PIDwith ARF6-T157A in Fig. 3. B, Route
2: ARF6-independent but PAK1-dependent pathway (AIP/PAK/RhoGDI/Rac)
that explainswhyPID alone reduced spinedensity in Fig. 3B.C, Route 3: ARF6-
and PAK1-dependent pathway (ARF6/PLD/PA/PAK/RhoGDI/Rac). In mature
neurons, another route is in operation.D, Route 4: ARF6-dependent and Rho-
dependent pathway (ARF6/PLD/PA/Rho) antagonizes the effect of Rac1 and
provides a strong negative impact on spine formation. The balance between
ARF6-T157A-induced Rac1 and RhoA activation via the PLDpathway, bypass-
ing PAK/RhoGDI pathway, plays a key role in the spine-reducing effect of
ARF6-T157A in mature neurons. AIP, ARF6-independent pathway.
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GEFs are enriched in neuronal postsynaptic densities and have
been linked to mental retardation and alterations in synaptic
modulation (51). Recent studies further identified two down-
stream ARF6 effectors, telencephalin (also known as intercel-
lular adhesion molecule-5) and vezatin (42, 43). Telencephalin
mainly localizes to dendritic filopodia and negatively regulates
spine development (43). ARF6-mediated endocytosis of telen-
cephalin increases dendritic spine stability regulated at least in
part by Rac1-mediated dephosphorylation and release of ezrin/
radixin/moesin actin-binding proteins from telencephalin (43).
Vezatin depletion significantly decreases total dendritic length
and arborization, whereas its overexpression increases the
length (42). Considering various ARF6 GEFs and GTPase-acti-
vating proteins that are activated to inducemyriad downstream
effects, many questions including the specificity and redun-
dancy of the various ARF6 GEFs and GTPase-activating pro-
teins as well as the exact method of ARF6 regulation of den-
dritic development require further detailed investigations.
All in all, we have provided evidence that ARF6 activation
bidirectionally regulates dendritic spine formation depending
on neuronal maturation and activity. Our results raise the pos-
sibility that activity-dependent dynamic changes in ARF6-me-
diated spine structuresmay play a role in structural plasticity of
mature neurons.
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